STOCK TITAN

Uipath Inc SEC Filings

PATH NYSE

Welcome to our dedicated page for Uipath SEC filings (Ticker: PATH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The UiPath, Inc. (NYSE: PATH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, giving investors and researchers a structured view of how this software publisher reports on its automation and AI business. As a public company, UiPath files documents with the U.S. Securities and Exchange Commission, including current reports on Form 8-K and other periodic filings.

Recent Form 8-K filings for UiPath include results of operations and financial condition, where the company furnishes press releases announcing quarterly financial results. These filings typically reference revenue performance, Annualized Renewal Run-rate (ARR), dollar-based net retention rate, and other operating metrics, along with management commentary on the progress of UiPath’s agentic automation strategy. Another 8-K filing details matters submitted to a vote of security holders at the annual meeting, such as director elections, advisory votes on executive compensation, and ratification of the independent registered public accounting firm.

UiPath also uses Form 8-K to disclose other material events, such as the adoption of a Rule 10b5-1 trading plan by an entity controlled by its founder and chief executive officer. That filing explains the plan’s purpose within a personal long-term investment strategy and notes that the shares subject to the plan represent a limited portion of the individual’s holdings, while the individual remains a significant controlling stockholder.

On Stock Titan, UiPath filings are updated as they appear on EDGAR, and AI-powered summaries help explain the substance of each document. Users can quickly understand the context of earnings-related 8-Ks, governance disclosures, and other material events without reading every line of the underlying filing. For more detailed analysis, investors can review the full text of each filing alongside these AI-generated overviews.

Rhea-AI Summary

UiPath (PATH) Form 4 filing: Director Philippe Botteri received an annual grant of 16,064 Restricted Stock Units (RSUs) on 26 Jun 2025 under the company’s non-employee director compensation policy. Each RSU converts into one Class A share when vested. The award vests on the earlier of the next annual meeting or the first anniversary of the grant date, provided the director remains in service.

The RSUs were issued at a price of $0.00, so no cash changed hands and no open-market transaction occurred. Following the grant, Botteri’s beneficial ownership rises to 3,160,889 Class A shares. No derivative securities or additional transactions were reported. The filing contains no other material corporate developments or financial metrics and is considered routine, with negligible dilution relative to UiPath’s total share count.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

UiPath (NYSE:PATH) CEO, Chairman and 10% owner Daniel Dines filed a routine Form 4 reporting the sale of 45,000 Class A shares on 06/27/2025 at an average price of $12.78 under a Rule 10b5-1 trading plan, for proceeds of roughly $0.58 million.

Dines still beneficially owns about 30.8 million shares: 24.9 million directly, 5.6 million through Ice Vulcan Holding Ltd., and 240,000 held by his spouse. The sale represents less than 0.2% of his holdings and does not affect his control position. No derivative securities were involved, and no other material changes were disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (NYSE:PATH) filed a Form 4 disclosing that CEO, Chairman and 10% owner Daniel Dines sold 45,000 Class A shares on 26 Jun 2025 at an average price of $12.38, generating about $0.56 million. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

After the sale, Dines still beneficially owns roughly 30.8 million shares (direct, indirect and spouse holdings), so the disposal represents well under 1% of his position. No other transactions or derivative movements were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (NYSE:PATH) filed a Form 4 showing CEO-Chairman Daniel Dines sold 45,000 Class A shares on 25 Jun 2025 at an average $12.55 under a Rule 10b5-1 plan. Post-sale, he still controls roughly 30.8 million shares, so the transaction equals <0.2% of his holdings and ≈$0.56 million in value—below materiality thresholds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.32%
Tags
insider
Rhea-AI Summary

UiPath CEO and Chairman Daniel Dines reported a significant insider transaction on June 24, 2025, selling 45,000 shares of Class A Common Stock at an average price of $12.4876 per share (ranging from $12.4150 to $12.5500). The transaction was executed through a pre-planned 10b5-1 trading plan.

Following the transaction, Dines maintains substantial holdings in UiPath:

  • 24,918,585 shares held directly
  • 5,733,376 shares held indirectly through Ice Vulcan Holding Limited
  • 240,000 shares held indirectly through spouse

As a Director, CEO, Chairman, and 10% Owner, Dines maintains significant control over the company. The shares held through Ice Vulcan Holding Limited are controlled by Dines through a corporate structure where he retains sole voting and investment power.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 23, 2025, at an average price of $12.096 per share through a pre-planned 10b5-1 trading plan.

Following the transaction, Dines maintains significant ownership positions:

  • 24,918,585 shares held directly
  • 5,778,376 shares held indirectly through Ice Vulcan Holding Limited
  • 240,000 shares held indirectly through spouse

The sale was executed through a qualified Rule 10b5-1 trading plan, with transaction prices ranging from $12.00 to $12.24. Dines serves multiple roles at UiPath including Director, CEO, Chairman, and qualifies as a 10% owner. The transaction was reported via Form 4 filed through his attorney-in-fact, Brad Brubaker.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

A Form 144 filing reveals that UiPath (NYSE: PATH) has reported a proposed sale of 1,000,000 shares of common stock with an aggregate market value of $12.37 million. The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of June 20, 2025.

The securities were originally acquired as Founders Shares from the issuer on April 21, 2021. The filing also discloses significant recent trading activity by ICE VULCAN HOLDING LIMITED through a 10b5-1 trading plan, with:

  • Regular sales of 45,000 shares per transaction over the past three months
  • Total sales of approximately 969,879 shares between May-June 2025
  • Sale prices ranging from $11.80 to $13.31 per share

This planned sale represents approximately 0.22% of UiPath's total outstanding shares of 457,586,105.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Uipath (PATH)?

The current stock price of Uipath (PATH) is $10.94 as of February 17, 2026.

What is the market cap of Uipath (PATH)?

The market cap of Uipath (PATH) is approximately 6.1B.

PATH Rankings

PATH Stock Data

6.05B
472.79M
Software - Infrastructure
Services-prepackaged Software
Link
United States
NEW YORK

PATH RSS Feed